cardiovascular conference: approach to a patient with cyanotic heart disease

65
CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Upload: sue

Post on 24-Feb-2016

38 views

Category:

Documents


0 download

DESCRIPTION

CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease. General Data:. Name: Baby Boy G Neonate born of a 22 year old primigravida. History of the Present Illness. Initial prenatal check-up 6 th month of pregnancy at local health center CBC, urinalysis normal - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

CARDIOVASCULAR CONFERENCE: Approach to a patient with

cyanotic heart disease

Page 2: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

General Data:

• Name: Baby Boy G• Neonate• born of a 22 year old primigravida

Page 3: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

History of the Present Illness

• Initial prenatal check-up– 6th month of pregnancy at local health center– CBC, urinalysis normal– UTZ (9/6/10): right ventricle appears collapsed

• Single live intrauterine pregnancy, cephalic, good cardiac and somatic activity, 24-25 weeks AOG, rule out hypoplastic right ventricle.

• Suggests congenital anomal scan scan with detailed cardiac evaulation preferably using fetal echocardiogram

– Referred to USTH

Page 4: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

September 8, 2010

• UTZ: 2nd and 3rd trimester– Single live intrauterine pregnancy of about 24-25

weeks in breech presentation with good cardiac and somatic activity

– Suggest fetal 2D echo c/o Dr. Cuaso

Page 5: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

September 8, 2010

• Assessment: Pregnancy 24-25 weeks AOG based on 2nd trimester ultrasound, t/c hypoplastic right ventricle

• Advised: – Multivitamins + FESO4 1 cap OD– Milk formula 1 glass OD– Request for CBC with blood typing, urinalysis, 50g OGCT– Request for congenital scan– Attend mother’s class every Saturday 10-11 am

Page 6: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

September 13, 2010Macroscopic Exam Result Microscopic Exam Result

Color Dark yellow WBC 24-26/hpf

Transparency Slightly turbid RBC 6-8/hpf

Reaction Acidic Mucus threads Moderate

Specific gravity 1.020 Epithelial cells Moderate

pH 6.0 Amorphous urates Many

Sugar Negative Bacteria

Protein negative Cast, parasites

Page 7: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

September 13, 2010Test Result

Hemoglobin 129 g/L

Hematocit 0.38

RBC count 4.07 x 10/L

WBC count 10.74 x10/L

Segmenters 0.68

Lymphocytes 0.30

Eosinophils 0.02

platelets adequate

Page 8: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

September 16, 2010

• OB GYN OPD– Speculum exam: cervix violaceous, smooth with

moderate frothy yellowish creamy discharge– Assessment: Trichomoniasis– Advised: Metronidazole 500 mg/tab 1 tab BID

• Fetal 2D Echo once with funds• 50g OGCT, repeat urinalysis clean catch

Page 9: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

September 24, 2010

• Follow-up• Unremarkable • Still for fetal 2D Echo, 50g OGCT

Page 10: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

October 5, 2010

• (+) terminal dysuria• Urinalysis

– Acidic– (++) bacteria– 2-5/hpf pus cells

• Normal OGCT results• Advised:

– Amoxicillin 500 mg/tab 1 tab q8 for 7 days– Once with 2D Echo results, refer to pediatric surgery

• (+) hyperemic conjunctiva OD- referred to Ophtha

Page 11: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

October 15, 2010

• USTH (October 11, 2010)– Fetal 2D- Echocardiogram: hypoplastic Left Ventricle,

hypoplastic Mitral Valve, and a patent foramen ovale– FHT 142

• Assessment: Pregnancy 29-30 weeks, hypoplastic left heart

• Advised: – Refer to pediatrics-cardiology and pediatric surgery

Page 12: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

November 22, 2010

• (+) persistence of dysuria• Assessment: Pregnancy 35-36 weeks AOG,

cephalic, Hypoplastic left ventricle, t/c UTI• Advised

– Urinalysis, Hepatitis B Ag, Blood typing

Page 13: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

November 25, 2010

• Assessment: UTI• Advised:

– Amoxicillin 500mg/cap 1 cap q8 for 7 days– Increase oral fluid intake

Page 14: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

November 25, 2010

• Pediatric Surgery Consult• Assessment: Pregnancy 36 weeks AOG, (?)

hypoplastic left ventricle• Plans: will evaluate any time after delivery

Page 15: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

November 26, 2010

• Blood type: AB+

Page 16: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

December 10, 2010

• UTZ: 2nd and 3rd trimester– There seems to be a mass in the interventricular

septum– Single live intrauterine pregnancy of about 35-36

weeks in cephalic presentation– BPS 8/8; SEFW 2823 grams– Cardiomegaly

• Suggest referral to Dr. Cuaso

Page 17: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

December 10, 2010

• High Risk OB GYN clinic• Assessment: Hypoplastic left ventricle,

hypoplastic mitral valve, UTI, r/o IUGR• Advised: Terraferon, Clusivol OB, Cefuroxime

500 mg/tab BID for 7 days– Repeat urinalysis after 7 days– BPS

Page 18: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

December 17, 2010

• UTZ: 38 weeks 6 days AOG• (-) dysuria• (+) fetal movements, irregular hypogastric pains,

SEFW p10-50• IE: 1 cm dilated, 60% effaced, (+) BOW, cephalic,

Stn -3• Assessment: Pregnancy 38-39 weeks, cephalic,

not in labor, ? Mass at the interventricular septum, UTI s/p treatment

Page 19: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

December 12, 2010

• UTZ: 2nd and 3rd trimester• Findings:

– There seems to be a mass at the interventricular septum

– Single live intrauterine pregnancy of about 35-36 weeks in cephalic presentation

– BPS 8/8; SEFW 2823 grams– Cardiomegaly– Suggest referral to Dr. Cuaso

Page 20: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

December 20, 2010

• For follow up • Supposedly for repeat Fetal 2D Echo• 3 cm dilated, 70% effaced intact BOW, there

was progression of labor alongside with spontaneous rupture of BOW.

• Clear, non-foul smelling amniotic fluid

Page 21: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Maternal History

• (-) exposure to radiation• (-) symptoms of viral exanthems• (-) use of illicit drugs and abortifacients • Non-smoker• Non drinker of alcoholic beverages• (-) hypertension, allergy, thyroid disease, diabetes,

asthma, liver disease, or blood dyscrasia – Hep B screening non-reactive– OGCT normal

Page 22: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Family HistoryName Age Relation Educational

AttainmentOccupation Health

MPG 22 Mother 2nd year nursing student

Student Healthy

LG 23 Father High school graduate

Unemployed Healthy

Page 23: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Family History

• No diabetes, hypertension, cardiac diseases, cancer, tuberculosis, allergies

• Denies hereditary illnesses

Page 24: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Physical Examination

• General Data– live, term, singleton, male, delivered via normal

spontaneous delivery– BW 2.75 kg, BL 48 cm– AS 6 and 7 at 5 minutes, MT 38-39 weeks – AGA

Page 25: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Physical Examination on Admission

• HR 134 bpm, RR 58 cpm, T 37.2˚C • Blue, pale, (+) circumoral cyanosis• (-) Rash, (-) birth marks, (+) palmar and plantar

cyanosis• (+) Molding, (+) caput succedaneum (-)

cephalhematoma• (+) ROR OU, (-) eye discharge, normal set ears, (-)

preauricular pits, patent nares, (-) Epstein’s pearls

Page 26: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Physical Examination on Admission

• (-) Palpable neck masses, intact clavicle, no crepitations

• (-) Chest deformities, symmetrical chest expansion, (-) retractions, clear and equal breath sounds, good respiratory effort

• Adynamic precordium, regular heart rate and rhythm, grade 1 holosystolic murmur at left parasternal area

• Globular abdomen, (+) umbilical stump with 2 arteries and 1 vein, (-) organomegaly, (-) palpable masses

Page 27: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

• Grossly male, bilaterally descended testes, good rugae, patent anus

• Femoral pulses full and equal, good flexion of extremities, (-) Barlow, (-) Ortolani

• Straight spine, (-) sacral dimpling, (-) tuft of hair

• (+) Moro, grasp, rooting, plantar, and sucking reflexes

Page 28: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

APPROACH TO DIAGNOSIS OF A PATIENT PRESENTING WITH CYANOSIS AT BIRTH

Page 29: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Indicators that heart disease may exist

• Cyanosis• Cardiomegaly (Radiologic or Pericardial bulge)• Pathologic heart murmur• Tachypnea or overt respiratory distress (dyspnea)• Sweating especially during feeding• Increased or decreased pulses• Failure to thrive

Page 30: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Classification of Congenital Heart Diseases

A) Acyanotic

B) Cyanotic

Page 31: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Major Considerations

• Is there a shunt (LR or RL)• Is there obstruction to inflow or outflow• Abnormal heart valves• Abnormal connections of great vessels• Combination

Page 32: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Subgroups of Acyanotic Diseases

• Shunt anomalies• Valvular defects• Obstructive lesions• Inflow anomalies• Primary myocardial diseases

Page 33: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Shunt Anomalies

• L R shunt• Increased pulmonary blood flow• Increased pulmonary vascular arterial

markings on chest Xray

• ASD, VSD, PDA

Page 34: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Obstructive Lesion

• Discrepancy in amplitude of the peripheral pulses

• Coarctation of the Aorta

Page 35: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Inflow Anomalies

• Increased pulmonary venous markings on chest Xray

• No murmur

• Cor Triatriatum, Pulmonary vein stenosis

Page 36: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Valvular Defects

• Stenosis or regurgitant• Characteristic murmur

• AS, AR, PS, PR, MS, MR, TS, TR

Page 37: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Primary Myocardial Diseases

• No murmur• Disparity between cardiac size and pulmonary

vascular markings

• Glycogen storage disease• Cardiomyopathy

Page 38: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Hemodynamic Consequences

A) Volume (Diastolic) overload

B) Pressure (Systolic) overload

Page 39: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

ASD

Hemodynamic Consequence

Diastolic overload of RV

Page 40: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

VSD• Hemodynamic

Consequence• MODERATE SIZE

– Volume overload of LV

• LARGE SIZE– Volume overload of

LV– Pressure overload of

RV

Page 41: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Cyanotic Heart Disease

• Cyanotic heart disease exist when one defect or association of defects allow the mixture of saturated and de-saturated blood to reach the systemic circulation

Page 42: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Do you suspect that patient is Cyanotic?

• When in doubtA) ClubbingB) CBCC) Hyperoxia test

Page 43: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Hyperoxia Test

• Hyperoxia test is considered positive for intracardiac shunting if PO2 < 150 mmHg (torr) after 10 minutes of 100% fiO2

Page 44: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

PVA / IVS• Hemodynamic

Consequence

• Pressure overload of RV

Page 45: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

PVA / VSD• Hemodynamic

Consequence

• Pressure overload of RV

Page 46: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

PDA Dependent Pulmonary Circulation

• Pulmonary valve atresia (PVA) with intact interventricular septum

• Other lesions with accompanying PVA

Page 47: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Approach to diagnosis

A) Chest Xray Increased or decreased pulmonary vascular arterial markings

B) EKG RVH, LVH, CVH

C) Character of second heart sound

S2 single, loudS2 single, normalSplit S2

Page 48: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Chest x-ray

Page 49: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Causes of Cyanosis

Noncardiac Cardiac

•Pulmonary disorders (structural abnormalities of the lung, ventilation-perfusion mismatching, congenital or acquired airway obstruction, pneumothorax, hypoventilation)•Abnormal forms of hemoglobin (methemoglobin)•Poor peripheral perfusion (sepsis, hypoglycemia, dehydration, hypoadrenalism)•primary or persistent pulmonary hypertension

Increased pulmonary vascularity•D-TGA•TAPVR without obstruction•PTA•Single ventricle•DORV w/o PS•PPHN

Decreased pulmonary vascularity•TOF•Ebstein’s anomaly•PS•PA•TA with PS•DORV with PS

Page 50: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Pulmonary Vascular MarkingsDecreased: Cyanotic

TOF Tricuspid Atresia

Complex heart with PS PVA / IVS

Page 51: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Second Heart Sound (S2)

Single Loud Single Normal Split S2

TGA TOF TAPVR without obstruction

Aortic / Mitral atresia

Tricuspid atresia

Truncus Arteriosus

PVA

Page 52: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Cardiac Work-Up

A) EKGB) Chest XrayC) 2D echocardiography

(TTE, TEE, ICE, IVUS)D) Cardiac catheterizationE) CT angiography, cardiac MRI

Page 53: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

• PLACE THE:– ECG– 2-D ECHO

Page 54: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Modalities of Management

A) PharmacologicB) Catheter based therapyC) Surgical

Page 55: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Pharmacologic

A) digoxin, diuretics, inotropes (pressor), vasodilators

B) Prostaglandin

Page 56: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Catheter Based Therapy (DI KO PA ALAM ITO, EXAMPLES LANG TO)

A) Balloon atrio septostomy (Rashkind)B) Balloon valvuloplastyC) Balloon angioplastyD) Delivery of occlusion devicesE) Radio frequency ablation

Page 57: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Surgical (DI KO PA ALAM ITO, EXAMPLES LANG TO)

A) Shunts like Modified Blalock-TaussigB) PA bandC) Complete repairD) Glenn, FontanE) NorwoodF) Jatene, Mustard, Senning

Page 58: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Course in the Wards

• 1:31 AM (12/21/10)– May feed 10-15mL FBM q3 with strict aspiration precautions– Keep O2 sat >62%– Refer to pedia cardio– Prewarmed radiant warmer– Labs: CBC with PC, CXR, 2D echo, 15L ECG– Routine newborn care

• Erythromycin strip 1cm OU• Vit K 1mg/IM• Hepa B vaccine 0.5mg/IM at lateral thigh• Cord care with 70% ethanol

Page 59: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease
Page 60: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Course in the Wards

• 7:30 AM (12/21/10)– Opted to withhold any further aggressive treatment

• 1:00PM (12/21/10)– Referral to pedia cardio answered

• 7:00 AM (12/22/10)– Feeding: 20-30mL FBM q3

• 9:00 AM (12/23/10)– Decision to take home baby

Page 61: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Course in the Wards

• 12:00 NN (12/23/10)• Discharge instructions

– Daily cord care with 70% ETOH q6– Daily bath with mild soap and lukewarm water– Daily sun exposure 7 to 9 AM for 15 min– Exclusive breastfeeding q2-q8 15 to 30min for each breast

• Discharge medications– Multivitamins 0.5mL/day

• Follow up at Pedia High Risk and cardio clinic• For hearing screening as out patient

Page 62: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

15L ECG

• Normal axis• Sinus tachycardia• LVH

Page 63: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

2D echo

• PDA• Pulmonary valve atresia• Intact ventricular septum• Hypertrophied right ventricle• Probably tripartite chamber• R->L shunt across formen ovale• Pulmonic annulus 5.6cm, MPA 5.22mm, RPA 5.0mm,

LPA 6.0mm• Normal aortic arch, coronary arteries, pulmonary veins

Page 64: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

CXR

• Lung fields are clear• Prominent cardiac silhouette• Suspicious prominence of pulmonary

vascularity• Normal hemidiagphragms and sinuses• Unremarkable visualized osseous structures

Page 65: CARDIOVASCULAR CONFERENCE: Approach to a patient with cyanotic heart disease

Lab resultsResult Result

Hemoglobin 171 g/L Neutrophils 0.62

RBC 4.74 x 10^12/L Metamyelocytes -

Hematocrit 0.51 Bands -

MCV 107.50 U^3 Segmented 0.62

MCH 36.10 pg Lymphocytes 0.35

MCHC 33.60 g/dL Monocytes 0.02

RDW 16.90 Eosinophils 0.01

MPV 8.30fL Basophils -

Platelet 227 x 10^9/L Note 1 nRBC/100 WBC

WBC 25.20 x 10^9/L Blood type B +